We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Masimo

Develops and manufactures non-invasive patient monitoring technologies, including medical devices and sensors read more Featured Products: More products

Download Mobile App




Forehead Sensor Facilitates Low Perfusion Pulse Oximetry

By HospiMedica International staff writers
Posted on 26 Jan 2017
An innovative transflectance sensor provides oxygen saturation measurements that are less susceptible to peripheral perfusion changes.

The TFA-1 single-patient-use adhesive forehead sensor allows clinicians to detection desaturation and resaturation faster than via digit sensors when using Masimo SET measure-through motion and low perfusion pulse oximetry, by addressing low perfusion and motion artifact challenges. More...
By harnessing adaptive filters to reduce measurement inaccuracy and the alternative forehead-monitoring site (rather than a finger), the TFA-1 provides easier access during surgery, resuscitation, and in patients with finger deformities.

The TFA-1 is suitable for both pediatric and adult patients, and is available in both Masimo LNCS and M-LNCS connector versions, each provided with a flat cable for improved patient comfort. Using a forehead sensor also avoids cross-contamination risks that accompany reusable sensors, reduces the complexity associated with reusable sensors, such as cleaning, storage, and transport. The TFA-1 single-patient-use adhesive forehead sensor is a product of Masimo, and has been approved by the U.S. Food and Drug Administration (FDA).

“The TFA-1 transflectance forehead adhesive sensor offers clinicians yet another way to leverage the breakthrough measurement capability in Masimo SET pulse oximetry,” said Joe Kiani, founder and CEO of Masimo. “By continuing to take Masimo's breakthrough technologies to new sites and applications, we are helping improve patient outcomes and safety while reducing cost of care.”

Masimo SET is a noninvasive sensor technology that uses more than seven wavelengths of light to acquire blood constituent data. Advanced signal processing algorithms and unique adaptive filters work together to isolate, identify, and quantify various hemoglobin species based on theur light absorption characteristics, delivering the results in numerical values. Masimo SET includes measurement of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVI), a measure of the dynamic changes in perfusion index that occur during the respiratory cycle.


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.